Position in PBH
as of Jun 30, 2026
· filed Aug 12, 2026
Position Value
$3,542,744
-$33,411,046 QoQ
Shares Held
74,947
-87.5% QoQ
Ownership
0.158%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#69
of 318 holders
Holding Since
Mar 2020
24 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in PBH Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026NORGES BANK holds $2,351,821,288 across 19 Drug Manufacturers - Specialty & Generic names. PBH ranks #15 (0.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | TEVA |
Teva Pharmaceutical Industries Ltd
|
32,299,753 | $1,094,315,631 | |
| 2 | UTHR |
UNITED THERAPEUTICS Corp
|
694,753 | $376,438,017 | |
| 3 | ZTS |
Zoetis Inc.
|
4,689,847 | $337,012,405 | |
| 4 | NBIX |
Neurocrine Biosciences Inc
|
973,880 | $164,137,735 | |
| 5 | ALKS |
Alkermes plc.
|
2,156,814 | $113,017,053 | |
| 6 | HLN |
Haleon plc
|
7,175,000 | $66,942,750 | |
| 7 | LNTH |
Lantheus Holdings, Inc.
|
586,845 | $65,104,584 | |
| 8 | VTRS |
Viatris Inc
|
3,822,744 | $60,705,174 |
All Filings in PBH
Export CSV
24 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $3,542,744 | 74,947 | Shares | Sole | 2026-08-12 | |
| 2025-12-31 | $36,953,790 | 599,024 | Shares | Sole | 2026-02-10 | |
| 2025-06-30 | $41,847,548 | 524,077 | Shares | Sole | 2025-08-13 | |
| 2025-03-31 | $45,054,899 | 524,077 | Shares | Sole | 2026-05-11 | |
| 2024-12-31 | $40,008,552 | 512,339 | Shares | Sole | 2025-02-12 | |
| 2024-09-30 | $36,394,926 | 504,784 | Shares | Sole | 2025-11-12 | |
| 2024-06-30 | $34,754,378 | 504,784 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $35,456,153 | 488,646 | Shares | Sole | 2025-05-14 | |
| 2023-12-31 | $27,738,904 | 453,102 | Shares | Sole | 2024-02-09 | |
| 2023-09-30 | $25,422,384 | 444,525 | Shares | Sole | 2024-11-13 | |
| 2023-06-30 | $26,418,120 | 444,525 | Shares | Sole | 2024-08-14 | |
| 2023-03-31 | $27,193,570 | 434,194 | Shares | Sole | 2024-05-15 | |
| 2022-12-31 | $35,335,884 | 564,471 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $26,240,478 | 526,600 | Shares | Sole | 2023-11-13 | |
| 2022-06-30 | $26,479,580 | 450,333 | Shares | Sole | 2023-08-14 | |
| 2022-03-31 | $24,875,711 | 469,885 | Shares | Sole | 2023-05-12 | |
| 2021-12-31 | $28,498,525 | 469,885 | Shares | Sole | 2022-03-09 | |
| 2021-09-30 | $31,212,926 | 556,281 | Shares | Sole | 2022-11-14 | |
| 2021-06-30 | $26,113,718 | 501,223 | Shares | Sole | 2022-08-15 | |
| 2021-03-31 | $23,900,043 | 542,197 | Shares | Sole | 2022-05-09 | |
| 2020-12-31 | $20,236,176 | 580,332 | Shares | Sole | 2021-03-02 | |
| 2020-09-30 | $22,086,107 | 606,428 | Shares | Sole | 2021-11-12 | |
| 2020-06-30 | $24,073,668 | 640,939 | Shares | Sole | 2021-08-13 | |
| 2020-03-31 | $23,465,369 | 639,732 | Shares | Sole | 2021-05-07 | |
| No filing history on record for this holder in this stock. | ||||||